➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Cefprozil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefprozil and what is the scope of patent protection?

Cefprozil is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Corden Pharma, Aurobindo Pharma Ltd, Chartwell Rx, Teva, and Wockhardt, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for cefprozil. Nine suppliers are listed for this compound.

Drug Prices for cefprozil

See drug prices for cefprozil

Drug Sales Revenue Trends for cefprozil

See drug sales revenues for cefprozil

Recent Clinical Trials for cefprozil

Identify potential brand extensions & 505(b)(2) entrants

The Affiliated Hospital of Qingdao UniversityPhase 1
Julio RamirezPhase 0
James Graham Brown Cancer CenterPhase 0

See all cefprozil clinical trials

US Patents and Regulatory Information for cefprozil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-001 Dec 23, 1991 DISCN Yes No   Get Started Free   Get Started Free   Get Started Free
Ranbaxy Labs Ltd CEFPROZIL cefprozil TABLET;ORAL 065198-001 Dec 13, 2006 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-002 Dec 23, 1991 DISCN Yes No   Get Started Free   Get Started Free   Get Started Free
Lupin CEFPROZIL cefprozil TABLET;ORAL 065276-002 Dec 8, 2005 AB RX No Yes   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.